What is a stock summary page? Click here for an overview.
Business Description
Rallybio Corp
NAICS : 541714
SIC : 2834
ISIN : US75120L1008
Description
Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 425.4 | |||||
| Equity-to-Asset | 0.91 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -6.57 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 8 | |||||
| 3-Year EPS without NRI Growth Rate | 10.3 | |||||
| 3-Year FCF Growth Rate | 14.3 | |||||
| 3-Year Book Growth Rate | -35.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 9.88 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 56.4 | |||||
| 9-Day RSI | 36.55 | |||||
| 14-Day RSI | 32.64 | |||||
| 3-1 Month Momentum % | -25.05 | |||||
| 6-1 Month Momentum % | -35.96 | |||||
| 12-1 Month Momentum % | -60.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.87 | |||||
| Quick Ratio | 10.87 | |||||
| Cash Ratio | 10.5 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -8.9 | |||||
| Shareholder Yield % | -41.7 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -9511.95 | |||||
| Net Margin % | -9084.12 | |||||
| FCF Margin % | -7748.74 | |||||
| ROE % | -70.83 | |||||
| ROA % | -63.56 | |||||
| ROIC % | -1303.34 | |||||
| 3-Year ROIIC % | -15965.59 | |||||
| ROC (Joel Greenblatt) % | -14121.38 | |||||
| ROCE % | -74.03 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 20.22 | |||||
| PB Ratio | 0.2 | |||||
| Price-to-Tangible-Book | 0.2 | |||||
| EV-to-EBIT | 0.88 | |||||
| EV-to-Forward-EBIT | -1.14 | |||||
| EV-to-EBITDA | 0.88 | |||||
| EV-to-Revenue | -83.33 | |||||
| EV-to-FCF | 1.08 | |||||
| Price-to-Net-Current-Asset-Value | 0.2 | |||||
| Price-to-Net-Cash | 0.21 | |||||
| Earnings Yield (Greenblatt) % | 113.64 | |||||
| FCF Yield % | -390.51 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RLYB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Rallybio Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.636 | ||
| EPS (TTM) ($) | -1.35 | ||
| Beta | -0.98 | ||
| 3-Year Sharpe Ratio | -0.33 | ||
| 3-Year Sortino Ratio | -0.46 | ||
| Volatility % | 37.26 | ||
| 14-Day RSI | 32.64 | ||
| 14-Day ATR ($) | 0.054152 | ||
| 20-Day SMA ($) | 0.369815 | ||
| 12-1 Month Momentum % | -60.02 | ||
| 52-Week Range ($) | 0.2201 - 2 | ||
| Shares Outstanding (Mil) | 41.61 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Rallybio Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Rallybio Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Rallybio Corp Frequently Asked Questions
What is Rallybio Corp(RLYB)'s stock price today?
The current price of RLYB is $0.30. The 52 week high of RLYB is $2.00 and 52 week low is $0.22.
When is next earnings date of Rallybio Corp(RLYB)?
The next earnings date of Rallybio Corp(RLYB) is 2025-05-09 Est..
Does Rallybio Corp(RLYB) pay dividends? If so, how much?
Rallybio Corp(RLYB) does not pay dividend.
Guru Commentaries on NAS:RLYB
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers